UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016803
Receipt number R000019502
Scientific Title Elucidation of structural and functional alterations of the preterm brain using advanced MR imaging
Date of disclosure of the study information 2015/03/17
Last modified on 2015/03/15 12:27:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Elucidation of structural and functional alterations of the preterm brain using advanced MR imaging

Acronym

Elucidation of alterations of the preterm brain using MRI

Scientific Title

Elucidation of structural and functional alterations of the preterm brain using advanced MR imaging

Scientific Title:Acronym

Elucidation of alterations of the preterm brain using MRI

Region

Japan


Condition

Condition

preterm infants

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

1) Elucidation of brain structure of the preter infant with cognitive or developmental disability.
2) Exploration of the early MR marker which predicts cognitive or divelopmental disability at age 6 in preterm infants.

Basic objectives2

Others

Basic objectives -Others

To explore the early MR marker for early intervention.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Brain MR images related to cognitive or developmental disability.

Key secondary outcomes



Base

Study type


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

Brain MRI is performed.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

7 years-old >=

Gender

Male and Female

Key inclusion criteria

Preterm infants whose gestational age at birth is 34 weeks or younger.

Key exclusion criteria

Contraindication of MRI

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name hiroyuki_kidokoro

Organization

Nagoya University Hospital

Division name

Pediatrics

Zip code


Address

65 Tsurumai-cho, Showa-ku, Nagoya

TEL

052-741-2111

Email

kidokoro@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name hiroyuki_kidokoro

Organization

Nagoya Univeristy Graduate School of Medicine

Division name

kido

Zip code


Address

65 Tsurumai-cho, Showa-ku, Nagoya

TEL

052-744-1901

Homepage URL


Email

kidokoro@med.nagoya.ac.jp


Sponsor or person

Institute

Department of Pediatrics, Nagoya University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

KAKEN

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 03 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2015 Year 03 Month 10 Day

Date of IRB


Anticipated trial start date

2015 Year 04 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 03 Month 15 Day

Last modified on

2015 Year 03 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019502